AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.
These devices provide healthcare professionals around the world with the vital tools they need to deliver high-quality patient care and improve patient outcomes.
Each day, AngioDynamics and its employees earn the trust of patients and the medical community by being a committed partner that continuously focuses on delivering safer, clinically-relevant and economically-favorable solutions that help improve patient outcomes.
AngioDynamics’ Response to the Coronavirus (COVID-19) Outbreak
AngioDynamics Appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer
American Urological Association (AUA)
Date: 15 May, 2020
Time:
Location: Washington, DC
AngioDynamics Launches PATHFINDER I Registry to Evaluate Performance and Clinical Outcomes of the AURYON™ Atherectomy System
AngioDynamics Reports Fiscal 2020 Second Quarter Financial Results
To the Customers of AngioDynamics:AngioDynamics is committed to the health and safety of our employees and to maintaining world-class service to our customers. We continue to monitor developments ...
AngioDynamics® history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach.
USA
International